Schlessinger Daniel I, Iyengar Sanjana, Yanes Arianna F, Henley Jill K, Ashchyan Hovik J, Kurta Anastasia O, Patel Payal M, Sheikh Umar A, Franklin Matthew J, Hanna Courtney C, Chen Brian R, Chiren Sarah G, Schmitt Jochen, Deckert Stefanie, Furlan Karina C, Poon Emily, Maher Ian A, Cartee Todd V, Sobanko Joseph F, Alam Murad
Department of Dermatology, Feinberg School of Medicine, Northwestern University, 676 North St. Clair Street, Suite 1600, Chicago, IL, USA.
Department of Dermatology, University of Pennsylvania, Philadelphia, PA, USA.
Trials. 2017 Aug 1;18(1):359. doi: 10.1186/s13063-017-2104-3.
Facial aging is a concern for many patients. Wrinkles, loss of volume, and discoloration are common physical manifestations of aging skin. Genetic heritage, prior ultraviolet light exposure, and Fitzpatrick skin type may be associated with the rate and type of facial aging. Although many clinical trials assess the correlates of skin aging, there is heterogeneity in the outcomes assessed, which limits the quality of evaluation and comparison of treatment modalities. To address the inconsistency in outcomes, in this project we will develop a core set of outcomes that are to be evaluated in all clinical trials relevant to facial aging.
METHODS/DESIGN: A long list of measureable outcomes will be created from four sources: (1) systematic medical literature review, (2) patient interviews, (3) other published sources, and (4) stakeholder involvement. Two rounds of Delphi processes with homogeneous groups of physicians and patients will be performed to prioritize and condense the list. At a consensus meeting attended by physicians, patients, and stakeholders, outcomes will be further condensed on the basis of participant scores. By the end of the meeting, members will vote and decide on a final recommended set of core outcomes. Subsequent to this, specific measures will be selected or created to assess these outcomes.
The aim of this study is to develop a core outcome set and relevant measures for clinical trials relevant to facial aging. We hope to improve the reliability and consistency of outcome reporting of skin aging, thereby enabling improved evaluation of treatment efficacy and patient satisfaction.
Core Outcome Measures in Effectiveness Trials (COMET) Initiative, accessible at http://www.comet-initiative.org/studies/details/737 . Core Outcomes Set Initiative, (CSG-COUSIN) accessible at https://www.uniklinikum-dresden.de/de/das-klinikum/universitaetscentren/zegv/cousin/meet-the-teams/project-groups/core-outcome-set-for-the-appearance-of-facial-aging . Protocol version date is 28 July 2016.
面部老化是许多患者关注的问题。皱纹、容量丧失和色素沉着是老化皮肤的常见体征。遗传因素、既往紫外线暴露以及菲茨帕特里克皮肤类型可能与面部老化的速度和类型有关。尽管许多临床试验评估了皮肤老化的相关因素,但所评估的结果存在异质性,这限制了治疗方式评估和比较的质量。为了解决结果的不一致性,在本项目中,我们将制定一套核心结果集,用于在所有与面部老化相关的临床试验中进行评估。
方法/设计:将从四个来源创建一长串可测量的结果:(1)系统的医学文献综述,(2)患者访谈,(3)其他已发表的来源,以及(4)利益相关者的参与。将对由医生和患者组成的同类小组进行两轮德尔菲法流程,以对列表进行优先排序和精简。在由医生、患者和利益相关者参加的共识会议上,将根据参与者的评分进一步精简结果。会议结束时,成员将进行投票并决定最终推荐的核心结果集。在此之后,将选择或创建具体的测量方法来评估这些结果。
本研究的目的是为与面部老化相关的临床试验制定一套核心结果集和相关测量方法。我们希望提高皮肤老化结果报告的可靠性和一致性,从而能够更好地评估治疗效果和患者满意度。